Ashland Inc. (ASH)
Chemicals • Basic Materials
Financial Metrics
Price to Earnings67.09x
Revenue Growth (1Y)-1.39%
Debt to Equity0.74x
Strengths
Valuation
Ashland Inc. is overvalued
News
All
Press Releases
News
Filings

August 07, 2026Ashland board authorizes quarterly dividend

July 29, 202610-Q Quarterly Report for 2026 Q3

July 28, 2026Ashland reports third quarter 2026 results and reaffirms full-year sales & Adjusted EBITDA outlook

July 28, 2026Ashland announces appointment of two new directors as part of Cooperation Agreement with stockholder Ancora

July 14, 2026Ashland sets date for third-quarter fiscal 2026 earnings release and conference call webcast

June 10, 2026Ashland responds to investor presentation by Ancora Alternatives LLC

May 18, 2026Ashland Board appoints Bertrand Loy as new director

May 05, 2026Ashland board authorizes quarterly dividend

April 29, 202610-Q Quarterly Report for 2026 Q2

April 28, 2026Ashland reports second quarter fiscal 2026 results and updates full-year outlook

April 15, 2026Ashland sets date for second-quarter fiscal 2026 earnings release and conference call webcast

March 23, 2026Ashland implements pricing actions across product portfolio in response to market volatility

March 17, 2026Ashland CFO to discuss current market environment at the Gabelli Funds’ 17th Annual Specialty Chemicals Symposium

February 09, 2026Ashland agrimer™ eco-coat polymer seed coating from the Transformed Vegetable Oils (TVO) platform receives approval for all food and non-food uses in pesticide formulations including for sale in the U.S.

February 03, 202610-Q Quarterly Report for 2026 Q1

February 02, 2026Ashland reports first quarter fiscal 2026 results and narrows full-year outlook

January 20, 2026Ashland sets date for first-quarter fiscal 2026 earnings release and conference call webcast

January 19, 2026Ashland board authorizes quarterly dividend

December 05, 2025Top 2 Materials Stocks That May Fall Off A Cliff This Quarter

December 01, 2025Silver Soars Past $58, Bitcoin-Strategy Bloodbath Deepens: What's Moving Markets Monday?

November 20, 202510-K Annual Report for 2025 FY

November 19, 2025Ashland board authorizes quarterly dividend

November 04, 2025Ashland reports fourth quarter fiscal 2025 results and issues outlook for full-year 2026

October 30, 2025Ashland changes start time for fourth-quarter fiscal 2025 earnings conference call webcast

October 23, 2025Ashland sets date for fourth-quarter fiscal 2025 earnings release and conference call webcast

October 14, 2025Ashland announces Sandy Klugman, director, investor relations

September 30, 2025Ashland production unit at Calvert City is offline, equipment requires replacement with no impact expected to customer orders

August 08, 2025Ashland board authorizes quarterly dividend

July 30, 202510-Q Quarterly Report for 2025 Q3

July 29, 2025Ashland reports third quarter fiscal 2025 results and narrows full-year outlook range

July 21, 2025Whitaker named senior vice president and chief financial officer, Ashland

July 16, 2025Ashland sets date for third-quarter fiscal 2025 earnings release and conference call webcast

July 14, 2025Operations leadership changes announced at Ashland

July 08, 2025Ashland advances strategic $60MM network optimization

May 28, 2025Ashland hosts Innovation Day for analysts and investors

May 05, 2025Ashland announces executive leadership changes

May 01, 202510-Q Quarterly Report for 2025 Q2

April 30, 2025Ashland reports second quarter fiscal 2025 results and revises full-year outlook

March 26, 2025This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

January 29, 202510-Q Quarterly Report for 2025 Q1

November 18, 202410-K Annual Report for 2024 FY

August 07, 202410-Q Quarterly Report for 2024 Q3

May 01, 202410-Q Quarterly Report for 2024 Q2

January 31, 202410-Q Quarterly Report for 2024 Q1

November 17, 202310-K Annual Report for 2023 FY

July 27, 202310-Q Quarterly Report for 2023 Q3

May 03, 202310-Q Quarterly Report for 2023 Q2

February 01, 202310-Q Quarterly Report for 2023 Q1

November 21, 202210-K Annual Report for 2022 FY

July 28, 202210-Q Quarterly Report for 2022 Q3

April 28, 202210-Q Quarterly Report for 2022 Q2

February 03, 202210-Q Quarterly Report for 2022 Q1

November 22, 202110-K Annual Report for 2021 FY
A. Company Overview
Ashland Inc. is a multinational specialty additives and materials corporation incorporated in Delaware, United States. The company is headquartered at 8145 Blazer Drive, Wilmington, Delaware. The designation "Ashland" encompasses Ashland Inc., its predecessors, and its consolidated subsidiaries unless otherwise specified. Operating with an acute awareness of sustainability, Ashland serves diverse consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company employs approximately 3,800 individuals globally and provides services to customers in over 100 countries.
Ashland's operational structure is categorized into reportable segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Unallocated and Other segment comprises corporate governance activities and certain legacy matters not falling into the primary segments.
B. Business Segments
Life Sciences
The Life Sciences segment is notable for supplying pharmaceutical solutions, nutrition enhancers, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. Key offerings include:
- Pharmaceutical Solutions: These encompass controlled-release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders.
- Nutrition Solutions: This category includes thickeners, stabilizers, emulsifiers, and various additives designed to improve mouthfeel and control moisture migration in food products.
- Nutraceuticals: Products aimed at weight management, joint comfort, stomach health, sports nutrition, and overall wellness. This segment also offers custom formulation, toll processing, and particle engineering solutions.
Life Sciences caters to a wide range of industries including pharmaceuticals and nutraceutical manufacturers, food and beverage producers, hospitals, and industrial manufacturers, with a substantial operational footprint across the Americas, Europe, and Asia Pacific.
Personal Care
The Personal Care segment delivers comprehensive product offerings impacting oral care (toothpaste and mouthwash ingredients), hair care, and skin care. Solutions include:
- Hair Care: Advanced styling polymers, conditioning agents, emulsifiers, and preservatives that enhance the quality of grooming products.
- Skin Care and Cosmetics: Ingredients focused on natural and sustainable solutions include biofunctional actives and specialty polymers.
- Household Solutions: A diverse array of ingredients developed for cleaning applications that include surface wetting agents and rheology modifiers.
The Personal Care segment has manufacturing facilities in several countries and caters to both multinational branded companies and smaller, niche firms.
Specialty Additives
Specialty Additives is focused on rheology and performance-enhancing products used in various industrial applications. This segment offers solutions for:
- Architectural Coatings: Products such as hydroxyethylcellulose (HEC) for thickening and application properties in paints.
- Construction Materials: Cellulose ethers and other additives that enhance properties like workability and adhesion in construction mixes.
- Industrial Applications: Performance additives including binders and surfactants that serve more than 30 industries.
This segment establishes its market presence through an emphasis on innovation and a vast portfolio of polymer-based solutions that cater to an array of customer needs.
Intermediates
The Intermediates segment is centered on the production of 1,4-butanediol (BDO) and related derivatives, including n-methylpyrrolidone. These products serve as critical chemical intermediates in engineering polymers and polyurethane production, as well as in specialty solvents applicable to various sectors, such as electronics and pharmaceuticals.
The Intermediates segment is also strategically integrated with the Life Sciences, Personal Care, and Specialty Additives segments as it supplies core materials essential for their production processes.
C. Manufacturing and Operational Facilities
Ashland operates numerous manufacturing and laboratory facilities across the globe. Life Sciences operates 19 facilities in nine countries, Personal Care has 15 manufacturing and lab facilities, and Specialty Additives has 11 such facilities. Infrastructure spans significant locations in the United States, Europe, and Asia, facilitating robust distribution networks essential for local and international markets.
D. Competition
The specialty additives and ingredients marketplace is characterized by intense competition due to its fragmented nature. Ashland competes on various criteria including product quality, performance, pricing, service, and innovation. Notably, larger competitors may possess more substantial financial resources, which impacts market share dynamics. Ashland continues to hone its competitive edge by refining its corporate brand while focusing on customer collaboration in product development.
E. Intellectual Property
Intellectual property serves as a cornerstone for Ashland's business advantage. A diverse portfolio of patents, trade secrets, formulas, and proprietary technologies safeguards its unique offerings. Trademarks further aid in distinguishing Ashland’s products in the marketplace.
F. Research and Development
Research and development at Ashland plays a crucial role in understanding market needs and transforming them into actionable technology platforms. The focus includes developing new chemistries, innovative technologies, and customer-specific solutions across various technology centers globally to drive competitiveness.
Stock Infos
SectorBasic Materials
IndustryChemicals
CEOGuillermo Novo
Dividends

Pharmaceutical Companies
Ashland Inc. supplies pharmaceutical solutions such as controlled-release polymers, disintegrants, and tablet coatings, which are critical for pharmaceutical manufacturers.

Nutritional Products
The company offers nutrition enhancers and nutraceutical products aimed at health and wellness, including dietary supplements that target various health benefits.

Chemical Manufacturing
Ashland operates in the specialty chemicals domain, providing additives for industrial applications, such as rheological modifiers for paints and coatings.

Biotechnology
The Life Sciences segment's focus on agricultural chemicals and nutrition solutions reflects a connection to biotechnology as it relates to enhancing food and health outcomes.

Food Production & Processing
Ashland provides solutions aimed at improving food products, including thickeners and stabilizers, making it relevant to food production.

Fertilizers & Pesticides
Ashland produces agricultural chemicals, which can be used in fertilizers and pesticides to enhance agricultural output.

Intangible Assets
Ashland Inc. possesses strong brands and proprietary formulations which provide a competitive edge in the specialty chemicals market, making it difficult for competitors to replicate their unique offerings.